Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Curia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Fillers, Diluents & Binders
Controlled & Modified Release
Thickeners and Stabilizers
Granulation
Topical
Direct Compression
Emulsifying Agents
Co-Processed Excipients
Film Formers & Plasticizers
Lubricants & Glidants
API Stability Enhancers
Surfactant & Foaming Agents
Chewable & Orodispersible Aids
Coating Systems & Additives
Disintegrants & Superdisintegrants
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
31
PharmaCompass offers a list of Bromfenac Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bromfenac Sodium manufacturer or Bromfenac Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bromfenac Sodium manufacturer or Bromfenac Sodium supplier.
PharmaCompass also assists you with knowing the Bromfenac Sodium API Price utilized in the formulation of products. Bromfenac Sodium API Price is not always fixed or binding as the Bromfenac Sodium Price is obtained through a variety of data sources. The Bromfenac Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromfenac Sodium Sesquihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromfenac Sodium Sesquihydrate, including repackagers and relabelers. The FDA regulates Bromfenac Sodium Sesquihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromfenac Sodium Sesquihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bromfenac Sodium Sesquihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bromfenac Sodium Sesquihydrate supplier is an individual or a company that provides Bromfenac Sodium Sesquihydrate active pharmaceutical ingredient (API) or Bromfenac Sodium Sesquihydrate finished formulations upon request. The Bromfenac Sodium Sesquihydrate suppliers may include Bromfenac Sodium Sesquihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Bromfenac Sodium Sesquihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bromfenac Sodium Sesquihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Bromfenac Sodium Sesquihydrate active pharmaceutical ingredient (API) in detail. Different forms of Bromfenac Sodium Sesquihydrate DMFs exist exist since differing nations have different regulations, such as Bromfenac Sodium Sesquihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bromfenac Sodium Sesquihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Bromfenac Sodium Sesquihydrate USDMF includes data on Bromfenac Sodium Sesquihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bromfenac Sodium Sesquihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bromfenac Sodium Sesquihydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bromfenac Sodium Sesquihydrate Drug Master File in Japan (Bromfenac Sodium Sesquihydrate JDMF) empowers Bromfenac Sodium Sesquihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bromfenac Sodium Sesquihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Bromfenac Sodium Sesquihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bromfenac Sodium Sesquihydrate suppliers with JDMF on PharmaCompass.
A Bromfenac Sodium Sesquihydrate written confirmation (Bromfenac Sodium Sesquihydrate WC) is an official document issued by a regulatory agency to a Bromfenac Sodium Sesquihydrate manufacturer, verifying that the manufacturing facility of a Bromfenac Sodium Sesquihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bromfenac Sodium Sesquihydrate APIs or Bromfenac Sodium Sesquihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Bromfenac Sodium Sesquihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Bromfenac Sodium Sesquihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bromfenac Sodium Sesquihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bromfenac Sodium Sesquihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bromfenac Sodium Sesquihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bromfenac Sodium Sesquihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bromfenac Sodium Sesquihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bromfenac Sodium Sesquihydrate suppliers with NDC on PharmaCompass.
Bromfenac Sodium Sesquihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromfenac Sodium Sesquihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromfenac Sodium Sesquihydrate GMP manufacturer or Bromfenac Sodium Sesquihydrate GMP API supplier for your needs.
A Bromfenac Sodium Sesquihydrate CoA (Certificate of Analysis) is a formal document that attests to Bromfenac Sodium Sesquihydrate's compliance with Bromfenac Sodium Sesquihydrate specifications and serves as a tool for batch-level quality control.
Bromfenac Sodium Sesquihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Bromfenac Sodium Sesquihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromfenac Sodium Sesquihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromfenac Sodium Sesquihydrate EP), Bromfenac Sodium Sesquihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromfenac Sodium Sesquihydrate USP).
